Eye involvement in children with primary focal segmental glomerulosclerosis

被引:0
|
作者
Fatih Ozaltin
Saskia Heeringa
Ceren Erdogan Poyraz
Yelda Bilginer
Sibel Kadayifcilar
Nesrin Besbas
Rezan Topaloglu
Seza Ozen
Friedhelm Hildebrandt
Aysin Bakkaloglu
机构
[1] Hacettepe University Faculty of Medicine,Unit of Nephrology, Department of Pediatrics
[2] University of Michigan,Department of Pediatrics
[3] Hacettepe University Faculty of Medicine,Department of Ophthalmology
来源
Pediatric Nephrology | 2008年 / 23卷
关键词
Childhood; Focal segmental glomerulosclerosis; Eye; Steroid-resistant nephrotic syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
Distinct eye abnormalities have been described in children with nephrotic syndrome, particularly in diffuse mesangial sclerosis (i.e. Pierson syndrome). The aim of the study was to investigate whether there were any associated ocular anomalies in children with steroid-resistant nephrotic syndrome (SRNS), all of whom had revealed primary focal segmental glomerulosclerosis in biopsy. Thirty-three SRNS patients (16 male, 17 female) with a median age of 10.5 years (range 3–25 years) were enrolled in the study. Twenty steroid-sensitive nephrotic syndrome (SSNS) patients (ten male, ten female) with a median age of 8 years (range 3–15 years) served as controls. All SRNS patients were examined by mutational analysis for mutations in the NPHS2, WT1, and LAMB2 genes. Nine out of 33 SRNS patients (27.2%) showed various eye abnormalities. However, no abnormal ocular findings were detected in any of the SSNS patients. Abnormal eye findings detected in SRNS patients were anisometropic amblyopia (n = 4), Mittendorf’s dots (n = 4), myopic astigmatism (n = 3) and exotropia (n = 1). Macular pigment changes (n = 1), posterior subcapsular opacities (n = 1) and cataract (n = 1) were considered as steroid-induced side effects. In four patients, more than one eye abnormality was found. Mutational analysis for the NPHS2, WT1 and LAMB2 genes revealed disease-causing mutations in 24.2% of patients. Homozygous NPHS2 mutations were detected in five patients (15.1%), all of whom had parental consanguinity. In three patients (9%) from non-consanguineous parents, heterozygous de novo WT1 mutations were detected as disease-causing mutations. No LAMB2 mutation was detected in any patient. While four out of five (80%) patients with homozygous NPHS2 mutations showed at least one abnormal ocular finding (i.e. Mittendorf’s dot or anisometric amblyopia), none of the patients with a WT1 mutation had ocular involvement. In conclusion, ocular involvement may accompany SRNS caused by primary focal segmental glomerulosclerosis (FSGS). Ophthalmologic evaluation at the time of diagnosis might be beneficial to characterize further the spectrum of this possible association.
引用
收藏
页码:421 / 427
页数:6
相关论文
共 50 条
  • [1] Eye involvement in children with primary focal segmental glomerulosclerosis
    Ozaltin, Fatih
    Heeringa, Saskia
    Poyraz, Ceren Erdogan
    Bilginer, Yelda
    Kadayifcilar, Sibel
    Besbas, Nesrin
    Topaloglu, Rezan
    Ozen, Seza
    Hildebrandt, Friedhelm
    Bakkaloglu, Aysin
    PEDIATRIC NEPHROLOGY, 2008, 23 (03) : 421 - 427
  • [2] Primary focal segmental glomerulosclerosis in children: prognostic factors
    R. Martinelli
    Alice Setsuko Okumura
    Luis José Pereira
    Heonir Rocha
    Pediatric Nephrology, 2001, 16 : 658 - 661
  • [3] Primary focal segmental glomerulosclerosis in children: prognostic factors
    Martinelli, R
    Okumura, AS
    Pereira, LJ
    Rocha, H
    PEDIATRIC NEPHROLOGY, 2001, 16 (08) : 658 - 661
  • [4] Diagnosis and primary care management of focal segmental glomerulosclerosis in children
    Wong, Angela Y.
    John, Rita Marie
    NURSE PRACTITIONER, 2018, 43 (09): : 28 - 37
  • [5] Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis
    Marcelo M. Abrantes
    Luis Sergio B. Cardoso
    Eleonora M. Lima
    Jose Maria P. Silva
    Jose S. Diniz
    Eduardo A. Bambirra
    Eduardo A. Oliveira
    Pediatric Nephrology, 2006, 21 : 482 - 489
  • [6] Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis
    Abrantes, MM
    Cardoso, LSB
    Lima, EM
    Silva, JMP
    Diniz, JS
    Bambirra, EA
    Oliveira, EA
    PEDIATRIC NEPHROLOGY, 2006, 21 (04) : 482 - 489
  • [7] Urinary podocytes in primary focal segmental glomerulosclerosis
    Hara, M
    Yanagihara, T
    Kihara, I
    NEPHRON, 2001, 89 (03): : 342 - 347
  • [8] Immunosuppressive treatment in primary focal segmental glomerulosclerosis
    Xu, Shizhang
    Xu, Gaosi
    Zeng, Lei
    JOURNAL OF NEPHROLOGY, 2012, 25 (05) : 626 - 635
  • [9] Mycophenolate mofetil for primary focal segmental glomerulosclerosis: systematic review
    Lau, Emily W. Y.
    Ma, Polly H. X.
    Wu, Xinyin
    Chung, Vincent C. H.
    Wong, Samuel Y. S.
    RENAL FAILURE, 2013, 35 (06) : 914 - 929
  • [10] Focal and segmental glomerulosclerosis in children: a longitudinal assessment
    Boyer, Olivia
    Moulder, Janelle K.
    Somers, Michael J. G.
    PEDIATRIC NEPHROLOGY, 2007, 22 (08) : 1159 - 1166